Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lilly to acquire CrossBridge Bio for up to $300m
Lilly will acquire all CrossBridge Bio shares for up to $300m, including an upfront and milestone payment, based on progress. Credit: JHVEPhoto / Shutterstock.com.
Lilly will acquire all CrossBridge Bio shares for up to $300m, including an upfront and milestone payment, based on progress. Credit: JHVEPhoto / Shutterstock.com.